PERRIGO Co plc
For the period ended Mar 29, 2025. Filed May 7, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 29, 2025 · Filed May 7, 2025
PRGO$16.95+6.9%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Segment and Geographic Information
NOTE 17 -SEGMENT AND GEOGRAPHIC INFORMATION
The tables below show select financial measures by reporting segment(1) (in millions):
| CSCA | CSCI | Unallocated | Total | |
|---|---|---|---|---|
| Total assets | $4,533.4 | $5,226.4 | $— | $9,759.8 |
| Property, plant and equipment, net | $758.8 | $154.4 | $— | $913.2 |
| Total assets | $4,687.6 | $4,960.1 | $— | $9,647.7 |
| Property, plant and equipment, net | $769.0 | $148.8 | $— | $917.8 |
| CSCA · CSCI · Unallocated · Total | |||||
|---|---|---|---|---|---|
| Net sales | $620.7 | $423.1 | $— | $1,043.9 | |
| Cost of sales | 420.7 | 230.9 | — | 651.6 | |
| Gross profit | 200.1 | 192.2 | — | 392.3 | |
| Gross margin | 32.2% | 45.4% | —% | 37.6% | |
| Operating expenses | |||||
| Distribution | 13.2 | 9.6 | — | 22.8 | |
| Research and development | 15.1 | 11.6 | — | 26.7 | |
| Selling | 56.8 | 89.3 | — | 146.2 | |
| Administration | 30.9 | 35.3 | 46.1 | 112.2 | |
| Impairment charges | — | 3.1 | — | 3.1 | |
| Restructuring | 20.1 | 3.8 | 5.5 | 29.4 | |
| Other operating (income) expense, net | — | — | 5.0 | 5.0 | |
| Total operating expenses | 136.1 | 152.7 | 56.6 | 345.4 | |
| Operating income (loss) | $64.0 | $39.6 | $(56.6) | $46.9 | |
| Operating income % | 10.3% | 9.4% | NM | 4.5% | |
| Interest expense, net | 39.0 | ||||
| Other (income) expense, net | (0.4) | ||||
| Income (loss) from continuing operations before income taxes | 8.3 | ||||
| CSCA | CSCI | Unallocated | Total | |
|---|---|---|---|---|
| Capital expenditures | $14.9 | $10.6 | $— | $25.5 |
| Depreciation/amortization | $35.3 | $44.6 | $— | $79.9 |
Note 17
| CSCA · CSCI · Unallocated · Total | |||||
|---|---|---|---|---|---|
| Net sales | $644.1 | $437.9 | $— | $1,082.1 | |
| Cost of sales | 490.6 | 233.8 | — | 724.4 | |
| Gross profit | 153.5 | 204.2 | — | 357.7 | |
| Gross margin | 23.8% | 46.6% | —% | 33.1% | |
| Operating expenses | |||||
| Distribution | 13.4 | 11.4 | — | 24.9 | |
| Research and development | 16.4 | 12.6 | — | 29.0 | |
| Selling | 52.1 | 98.1 | — | 150.3 | |
| Administration | 39.4 | 39.9 | 51.1 | 130.4 | |
| Restructuring | 16.5 | 15.5 | 12.3 | 44.3 | |
| Other operating (income) expense, net | — | — | 34.0 | 34.0 | |
| Total operating expenses | 137.8 | 177.6 | 97.4 | 412.9 | |
| Operating income (loss) | $15.7 | $26.5 | $(97.4) | $(55.2) | |
| Operating income % | 2.4% | 6.1% | NM | (5.1)% | |
| Interest expense, net | 43.0 | ||||
| Other (income) expense, net | 0.4 | ||||
| Income (loss) from continuing operations before income taxes | (98.6) | ||||
| CSCA | CSCI | Unallocated | Total | |
|---|---|---|---|---|
| Capital expenditures | $18.2 | $6.9 | $— | $25.1 |
| Depreciation/amortization | $33.2 | $48.2 | $— | $81.4 |
(1) Amounts may not add or recalculate due to rounding. Percentages are based on actuals.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.